The Verification Review pathway has been developed by the Philippine Food and Drug Administration (FDA) of Philippines.
This pathway can be used where New drugs, vaccines, and biologicals. All generic products with FDA-approved equivalents shall not be considered new drugs. .
When relevant, the agency relies on prior decisions from Australia Belgium Canada EU-EMA France Germany Italy Japan Netherlands Singapore Switzerland United Kingdom United States WHO
The turnaround time shall start after receipt of the proof of payment with the complete application dossier. Verification review will take not more than 30 working days.